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BaCkground
Many high- profile athletes participate across a wide 
range of sports with type 1 diabetes. Team Type 1 
encourages and supports those with type 1 diabetes 
to participate in physical activity, with professional 
cycling’s Team Novo Nordisk composed entirely 
of individuals with type 1 diabetes. Type 1 diabetes 
is likely to present early in an athlete’s career, a 
time when athletes may present with fatigue due 
to increased training loads. All physicians need to 
distinguish between possible causes of fatigue in 
these athletes.
Type 1 diabetes is an autoimmune condition with 
T- cell- mediated destruction of the pancreatic β cells 
of the islets of Langerhans, resulting in failure to 
produce sufficient insulin. The clinical outcome is 
an inability to adequately control glucose metab-
olism. Effective glucose metabolism is crucial in 
long- duration and high- intensity exercise. Self- 
administered exogenous insulin is required as a 
treatment to manage blood glucose.
The physiological response to exercise is a 
progressive decrease in insulin and increase in 
the pancreatic α-cell- derived antagonist hormone 
glucagon, while exercise also increases insulin 
sensitivity (increased ‘sensitivity’ means that for a 
given dose, there is a more pronounced effect—
insulin does its job ‘better’). In addition, there is an 
exercise- induced rise in sympathoadrenal hormones 
(epinephrine and norepinephrine). This hormonal 
response influences circulating glucose and fat use, 
and is usually well- regulated. This is not the case 
in athletes with type 1 diabetes, where there is a 
substantial risk of both hyperglycaemia and hypo-
glycaemia. Patients often have the low bottom of 
range blood glucose for many hours after exercise.1 
Individual with type 1 diabetes often need 48 hours 
to reset their autonomic function and replenish 
glycogen stores.2
CasE: rowEr wiTh a Big ThirsT, wEighT 
loss and faTiguE
An 18- year- old first- year university rower noticed 
that during an off- site training camp he was drinking 
a lot of water and losing weight, which he put down 
to maladaptation to the high training load in a hot 
climate. However, symptoms worsened when he 
returned to campus after the training camp. He 
reported feeling extremely fatigued, weak and sick, 
and was admitted to hospital. Following a formal 
diagnosis of type 1 diabetes, he reported receiving 
very little advice on discharge—what was offered 
was very generalised and there was no follow- up 
appointment offered. So he researched how to 
manage diabetes while exercising and looking for 
recommendations specific to rowing. He reported 
that information gave him the confidence to try to 
manage the condition and continue with his chosen 
sports.
CliniCal quEsTions
 ► How can clinicians raise awareness of type 1 
diabetes as a possible cause of fatigue in active 
individuals and hence identify these athletes?
 ► How can we educate athletes with sports- 
specific information and support?
CliniCal fEaTurEs
history
Athletes may present with fatigue, polydipsia, poly-
uria and weight loss. There may be recent episodes 
of infective illness. Athletes may also present 
initially with acute signs and symptoms consistent 
with diabetic ketoacidosis.
Examination
Examination should be relevant to the athlete’s 
presenting complaint. If there is a high clinical 
suspicion of type 1 diabetes, then examine for any 
vitiligo that may indicate an autoimmune disease. 
Funduscopy/retinal photography can also be 
considered at this stage.
diagnostic tests
These should include routine bloods tests (full 
blood count, renal profile, blood glucose, liver 
function and thyroid function) and glycosylated 
haemoglobin (HbA1c). Oral glucose tolerance test 
may be considered. Testing for β cell antibodies may 
be considered in those aged <45 years at diagnosis.
According to the WHO diagnostic criteria 2010, 
confirmation of diabetes mellitus diagnosis in a 
person with hyperglycaemic symptoms is with 
random/postprandial blood glucose ≥11.1 mmol/L 
(200 mg/dL), or fasting blood glucose ≥7.0 mmol/L 
(126 mg/dL).3
ManagEMEnT
The aim is to mimic the natural physiological 
response of glucose metabolism to exercise.3 
Figure 1 summarises the key principles of manage-
ment. Management is subject to a number of 
considerations:
 ► Insulin sensitivity: 0.5 unit/kg is required to 
reduce blood glucose by 4 mmol/L.
 ► Insulin should be injected into the non- 
exercising muscle, as hyperaemia will be present 
in exercising muscle.
 ► Peak insulin bolus occurs 60–80 min post injec-
tion, with peak reduction of blood glucose 
occurring 90–120 min postinjection.
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figure 1 Management of diabetes in athletes.
The objective is to manage insulin levels while athletes are 
training/racing. To achieve this, strategies revolve around 
injecting a lower dose of insulin and/or more carbohydrate 
intake, including4 5:
 ► Reducing bolus insulin before exercise.
 ► Ensuring carbohydrate intake during exercise.
 ► Replenishing glycogen stores postexercise with a range of 
options: a carbohydrate- rich and protein- rich meal intake, 
reduction of bolus insulin with the next meal and reduction 
of basal evening insulin to avoid overnight hypoglycaemia.
ongoing CarE
Soon after an athlete is diagnosed with type 1 diabetes, there can 
be a ‘honeymoon period’ when exogenous insulin requirements 
are not high, due to residual β cell function: athletes should 
be alerted to the importance of monitoring blood glucose and 
modifying insulin doses appropriately. Dietary advice should be 
offered by an appropriately qualified dietician; this will include 
guidance on daily intake, in particular, carbohydrate and timing 
of intake around exercise training and competition.6
Insulin is on the banned WADA list both in and out of competi-
tion, so athletes with type 1 diabetes require therapeutic medical 
exemption.7
PraCTiCal TiPs
 ► Always consider the possibility of type 1 diabetes mellitus in 
athletes presenting with fatigue.
 ► Provide adequate generic and sports- specific education.
 ► Empower and support athlete to make personalised changes 
to optimise their glucose management.
 ► Encourage support from teammates and coaches. Identify 
the location of the emergency source of glucose during 
training/competition.
 ► Mentorship of athletes from fellow athletes with type 1 
diabetes can be beneficial.
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